To prevent diseases from occurring in the first place, it is important to identify those individuals who are at particularly high risk as early as possible. Yet current screening methods are often costly and focus only on one disease at a time.…

BRCA1/2-mutated tumor cells often survive treatment, whether it’s chemo- or radiotherapy, because they can repair therapy-induced DNA damage. A team led by Claus Scheidereit of the Max Delbrück Center has now reported in The EMBO Journal how blocking…

Optimized sample preparation workflows facilitate single cell proteomics applications

If a secretion in the lungs’ alveoli is not cleared regularly, breathing difficulties can develop. In a study published in Science Immunology, a team led by Alexander Mildner and Achim Leutz has now explained the pivotal role of the transcription…

An international research consortium led by the Berlin Institute of Health at Charité (BIH) has secured funding of €7.5 million through the EU’s current Horizon Europe program. The goal of the participating scientific and clinical specialists is to…

Oversubscribed financing round with top-tier life science investors, led by Wellington Partners | Spin-off from Charité – Universitätsmedizin Berlin developing sophisticated AI models to improve understanding, diagnosis and treatment of complex…

- NextPharma to Acquire Takeda’s Manufacturing Site in Asker, Norway

- The Asker Site No Longer Produces Finished Products for Takeda

- Deal Closing is Expected around March 2023

New Neuropixels technology provides evidence of mosaic-like neural connections

ProBioGen and City of Hope, one of the largest cancer research and treatment organizations in the United States, announced today a non-exclusive commercial license agreement that will allow City of Hope to manufacture its innovative synthetic…

MyoPax, a new spin-off of the Max Delbrück Center and Charité, receives a 1.3 million euros loan to jump-start its entrepreneurial activities. The start-up develops regenerative therapies for previously incurable muscle diseases using its innovative…